JUNEAU, Alaska (April 12, 2017) – On Monday, the Alaska House unanimously passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Rep. Jason Grenn (I-Anchorage) introduce House Bill 43 (HB43) in January. The legislation would…
PROVIDENCE, R.I. (April 11, 2017) – Last week, a Rhode House committee recommended passage of a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Rep. Joseph McNamara (D) introduced House Bill 5676 (HB5676), along with a…
ANNAPOLIS, Md. (April 10, 2017) – Today, the Maryland House gave final approval to a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584…
PROVIDENCE, R.I. (April 6, 2017) – Yesterday, a Rhode Island House committee passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. A bipartisan coalition of five representatives introduced House Bill 5676 (HB5676) on March 1.…
ANNAPOLIS, Md. (March 30, 2017) – Yesterday, the Maryland Senate unanimously passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Sen. Bryan W. Simonaire (R) introduced Senate Bill 572 (SB572), along with a bipartisan coalition…
HARRISBURG, Pa. (March 27, 2017) – A Pennsylvania bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients unanimously passed out of an important House committee last week. Introduced by State Rep. Robert Godshall (R-Hatfield) and nearly 40…
ANNAPOLIS, Md. (March 21, 2017) – Yesterday, the Maryland House unanimously passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584 (HB584) would…
While the FDA would have let all these people die, the Texas Right to Try Act – along with the heroic actions of Dr. Delpassand – has given them hope.
DES MOINES, Iowa (March 16, 2017) – On Tuesday, the Iowa Senate unanimously passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. The Senate Commerce Committee introduced Senate Bill 404 (SF404) on March 1. The…
SANTE FE, N.M. (March 15, 2017) – A New Mexico bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients unanimously passed the House last week. Introduced by Rep. Rebecca Dow (R-Grant), House Bill 228 (HB228) would give…